These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8098972)

  • 1. [Intravenous administration of immunoglobulins for prevention of bacterial and viral infections in children with symptomatic HIV infection].
    Shearer WT
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():78-9; discussion 80. PubMed ID: 8098972
    [No Abstract]   [Full Text] [Related]  

  • 2. [Skin diseases in human immunodeficiency virus positive children from Santiago, Chile].
    Muñoz M P; Gómez H O; Luzoro V A
    Rev Chilena Infectol; 2008 Aug; 25(4):277-82. PubMed ID: 18769774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immune globulin for the prevention of bacterial infections in children with symptomatic human immunodeficiency virus infection.
    National Institute of Child Health and Human Developments Intravenous Immunoglobulin Study Group
    N Engl J Med; 1991 Jul; 325(2):73-80. PubMed ID: 1675763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of atovaquone and azithromycin with trimethoprim-sulfamethoxazole for the prevention of serious bacterial infections in children with HIV infection.
    Hughes WT; Dankner WM; Yogev R; Huang S; Paul ME; Flores MA; Kline MW; Wei LJ;
    Clin Infect Dis; 2005 Jan; 40(1):136-45. PubMed ID: 15614703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin therapy in older infants and children.
    Fischer GW
    Infect Dis Clin North Am; 1992 Mar; 6(1):97-116. PubMed ID: 1578124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of zidovudine treatment of 9 vertically HIV infected children].
    Berkefeld I; Fuchs A; Wahn V
    Monatsschr Kinderheilkd; 1993 Jun; 141(6):498-504. PubMed ID: 8101636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immune globulin for the prevention of infections in children with symptomatic human immunodeficiency virus infection.
    Mofenson LM; Moye J
    Pediatr Res; 1993 Jan; 33(1 Suppl):S80-7; discussion S87-9. PubMed ID: 8433880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic intravenous immunoglobulin in HIV-infected children with CD4+ counts of 0.20 x 10(9)/L or more. Effect on viral, opportunistic, and bacterial infections. The National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group.
    Mofenson LM; Moye J; Bethel J; Hirschhorn R; Jordan C; Nugent R
    JAMA; 1992 Jul 22-29; 268(4):483-8. PubMed ID: 1352363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiological infections in HIV positive Bahraini patients with low CD4+ T-lymphocyte count.
    Ehrahim RA; Farid EM; Yousif A; Jamsheer AE
    J Commun Dis; 2002 Sep; 34(3):160-70. PubMed ID: 14703050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of HIV-related skin disease. Part I: infections.
    Osborne GE; Taylor C; Fuller LC
    Int J STD AIDS; 2003 Feb; 14(2):78-86; quiz 87-8. PubMed ID: 12662385
    [No Abstract]   [Full Text] [Related]  

  • 11. [The use of hyperimmune anti-cytomegalovirus immunoglobulins in HIV infection].
    Mancuso S; Abbadessa V; Perricone R; Cajozzo A
    Recenti Prog Med; 1996 Jun; 87(6):267-70. PubMed ID: 8766951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in CD4 count with antitubercular therapy in HIV infected children with tuberculosis.
    Mukherjee A; Lodha R; Kabra SK
    J Trop Pediatr; 2009 Apr; 55(2):125-7. PubMed ID: 18829637
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of infections in the patient with acquired immunodeficiency syndrome.
    Smith GH
    Arch Intern Med; 1994 May; 154(9):949-73. PubMed ID: 8179453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure to control growth of mycobacteria in blood from children infected with human immunodeficiency virus and its relationship to T cell function.
    Tena GN; Young DB; Eley B; Henderson H; Nicol MP; Levin M; Kampmann B
    J Infect Dis; 2003 May; 187(10):1544-51. PubMed ID: 12721934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDC-defined diseases and opportunistic infections in Jamaican children with HIV/AIDS.
    Pierre R; Steel-Duncan JC; Evans-Gilbert T; Rodriguez B; Palmer P; Smikle MF; Whorms S; Hambleton I; Figueroa JP; Christie CD
    West Indian Med J; 2004 Oct; 53(5):315-21. PubMed ID: 15675497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIV-positive: recommendations for tropical travel. Preventive measures--vaccination].
    Kreutzberg K
    Fortschr Med; 1994 Jan; 112(1-2):20-1. PubMed ID: 7908277
    [No Abstract]   [Full Text] [Related]  

  • 19. [Practical use of gamma globulins in children].
    Geubelle F; Laloux F
    Rev Med Liege; 1979 Jan; 34(1):13-8. PubMed ID: 83666
    [No Abstract]   [Full Text] [Related]  

  • 20. Anti-HIV genetic treatment of antigen-specific human CD4 lymphocytes for adoptive immunotherapy of opportunistic infections in AIDS.
    Manca F; Fenoglio D; Franchin E; Saverino D; Li Pira G; Buffa F; Bignardi D; Del Pup L; Palù G
    Gene Ther; 1997 Nov; 4(11):1216-24. PubMed ID: 9425445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.